{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:25:04Z","timestamp":1767597904411,"version":"3.41.2"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T00:00:00Z","timestamp":1718928000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Fibroblast growth factor 23 (FGF-23) and other markers of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD) provide valuable insights into disease processes, treatment options and patient prognosis. However, limited research has explored potential associations with ethnicity or season, particularly in multi-ethnic populations residing in high-latitude regions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We evaluated CKD-BMD markers in a diverse cohort of CKD patients, who were participants of The CANADIAN AIM to PREVENT (the CAN AIM to PREVENT) study. FGF-23, calcium, phosphate, 25-hydroxyvitamin D (25-OHD) and intact parathyroid hormone (iPTH) in 1234 participants with pre-dialysis CKD (mean estimated glomerular filtration rate: 41.8\u00a0\u00b1\u00a014.3\u00a0mL\/min) were analyzed. Mixed-effects general linear regression models adjusted for demographic and biological factors were used to compare repeated measurements across patient groups categorized by ethnicity (East Asian, White, South Asian, Black, Southeast Asian) and seasons.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with other groups, White participants exhibited 8.0%\u201318.5% higher FGF-23 levels, Black participants had 0.17\u20130.32\u00a0mg\/dL higher calcium levels, White participants had 10.0%\u201320.1% higher 25-OHD levels, South Asian participants had 7.3%\u201320.1% lower 25-OHD levels and Black participants had 22.1\u201373.8% higher iPTH levels, while East Asian participants had 10.7%\u201373.8% lower iPTH levels. Seasonal variations were also observed. FGF-23 levels were 11.9%\u201315.5% higher in summer compared with other seasons, while calcium levels were 0.03\u20130.06\u00a0mg\/dL lower in summer. 25-OHD levels were 5.6%\u201310.6% higher in summer and autumn compared with other seasons.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study shows that FGF-23 and CKD-MBD markers in a Canadian pre-dialysis CKD cohort vary independently by ethnicity and season. Further research is needed to understand the reasons and clinical significance of these findings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfae188","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T22:19:00Z","timestamp":1718835540000},"source":"Crossref","is-referenced-by-count":5,"title":["Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease\u2013mineral and bone disorder"],"prefix":"10.1093","volume":"17","author":[{"given":"Hulya","family":"Taskapan","sequence":"first","affiliation":[{"name":"Research Department, Kidney Life Sciences Institute , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Mahdavi","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health , Boston , USA"},{"name":"Department of Medicine, University of Canada , Toronto , Canada"},{"name":"Department of Nephrology, The Scarborough Health Network , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-1645","authenticated-orcid":false,"given":"Antonio","family":"Bellasi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ente Ospedaliere Cantonale , Lugano , Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salome","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Scarborough Health Network , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeeda","family":"Kuvadia","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Scarborough Health Network , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anfal","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Canada , Toronto , Canada"},{"name":"Department of Nephrology, The Scarborough Health Network , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berkay","family":"Taskapan","sequence":"additional","affiliation":[{"name":"Research Department, Kidney Life Sciences Institute , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Tam","sequence":"additional","affiliation":[{"name":"Research Department, Kidney Life Sciences Institute , Toronto , Canada"},{"name":"Department of Medicine, University of Canada , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabo","family":"Sikaneta","sequence":"additional","affiliation":[{"name":"Research Department, Kidney Life Sciences Institute , Toronto , Canada"},{"name":"Department of Medicine, University of Canada , Toronto , Canada"},{"name":"Department of Nephrology, The Scarborough Health Network , Toronto , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"2024072610152966300_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"2024072610152966300_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jbmr.2606","article-title":"FGF23 Regulates bone mineralization in a 1,25(OH)2 D3 and klotho-independent manner","volume":"31","author":"Murali","year":"2016","journal-title":"J Bone Miner Res"},{"key":"2024072610152966300_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/labinvest.2008.114","article-title":"Recent advances in the renal\u2013skeletal\u2013gut axis that controls phosphate homeostasis","volume":"89","author":"Kiela","year":"2009","journal-title":"Lab Invest"},{"key":"2024072610152966300_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S2213-8587(17)30310-8","article-title":"Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population","volume":"6","author":"Covic","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024072610152966300_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000486060","article-title":"Physiology of the calcium-parathyroid hormone-vitamin D axis","volume":"50","author":"Goltzman","year":"2018","journal-title":"Front Horm Res"},{"key":"2024072610152966300_bib6","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"2024072610152966300_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"2024072610152966300_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ki.1992.22","article-title":"Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease","volume":"41","author":"Koenig","year":"1992","journal-title":"Kidney Int"},{"key":"2024072610152966300_bib9","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"2024072610152966300_bib10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","article-title":"The Kidney Disease Outcomes Quality Initiative (K\/DOQI) guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients","volume":"46","author":"Noordzij","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2024072610152966300_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000444890","article-title":"Changes in markers of mineral and bone disorders and mortality in incident hemodialysis patients","volume":"43","author":"Soohoo","year":"2016","journal-title":"Am J Nephrol"},{"key":"2024072610152966300_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s40620-020-00715-2","article-title":"Fibroblast growth factor 23: are we ready to use it in clinical practice?","volume":"33","author":"Bouma-de Krijger","year":"2020","journal-title":"J Nephrol"},{"key":"2024072610152966300_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","journal-title":"Kidney Int Suppl"},{"key":"2024072610152966300_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12882-020-01852-3","article-title":"Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review","volume":"21","author":"Hounkpatin","year":"2020","journal-title":"BMC Nephrol"},{"key":"2024072610152966300_bib15","doi-asserted-by":"crossref","first-page":"ii99","DOI":"10.1093\/ndt\/gfw379","article-title":"Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA","volume":"32","author":"Obi","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2024072610152966300_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1681\/ASN.V112330","article-title":"Race is a major determinant of secondary hyperparathyroidism in uremic patients","volume":"11","author":"Gupta","year":"2000","journal-title":"J Am Soc Nephrol J Am Soc Nephrol"},{"key":"2024072610152966300_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"2024072610152966300_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bone.2019.03.003","article-title":"Seasonal variation of serum 25-hydroxyvitamin D and parameters of bone and mineral disorder in dialysis patients","volume":"124","author":"Kleine","year":"2019","journal-title":"Bone"},{"key":"2024072610152966300_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2215\/CJN.08020715","article-title":"Genetic African ancestry and markers of mineral metabolism in CKD","volume":"11","author":"Guti\u00e9rrez","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024072610152966300_bib20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jbmr.4182","article-title":"Race and ethnicity predict bone markers and fracture in pediatric patients with chronic kidney disease","volume":"36","author":"Laster","year":"2021","journal-title":"J Bone Miner Res"},{"key":"2024072610152966300_bib21","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ki.2008.4","article-title":"Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease","volume":"73","author":"Guti\u00e9rrez","year":"2008","journal-title":"Kidney Int"},{"key":"2024072610152966300_bib22","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/ndt\/gfs080","article-title":"Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD","volume":"27","author":"Ennis","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"2024072610152966300_bib23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000479300","article-title":"Fibroblast growth factor 23 predicts mortality and end-stage renal disease in a Canadian Asian population with chronic kidney disease","volume":"137","author":"Jialal","year":"2017","journal-title":"Nephron"},{"key":"2024072610152966300_bib24","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2024072610152966300_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/cen.12163","article-title":"Parathyroid hormone and arterial dysfunction in the multi- ethnic study of atherosclerosis","volume":"79","author":"Bosworth","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024072610152966300_bib26","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1359\/jbmr.2001.16.9.1704","article-title":"Milk supplementation of the diet of postmenopausal Chinese women on a low calcium intake retards bone loss","volume":"16","author":"Lau","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2024072610152966300_bib27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ejcn.2012.54","article-title":"High-calcium, vitamin D fortified milk is effective in improving bone turnover markers and vitamin D status in healthy postmenopausal Chinese women","volume":"66","author":"Kruger","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"2024072610152966300_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2024072610152966300_bib29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00403-022-02415-2","article-title":"Sun protective behaviors in sun-sensitive individuals: a cross-sectional study examining for ethnic and racial differences","volume":"315","author":"Bolick","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"2024072610152966300_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1017\/S1368980013002929","article-title":"Vitamin D intakes of adults differ by income, gender and race\/ethnicity in the USA, 2007 to 2010","volume":"17","author":"Moore","year":"2014","journal-title":"Public Health Nutr"},{"key":"2024072610152966300_bib31","doi-asserted-by":"crossref","first-page":"F1042","DOI":"10.1152\/ajprenal.90771.2008","article-title":"The A563T variation of the renal epithelial calcium channel TRPV5 among African Americans enhances calcium influx","volume":"296","author":"Na","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"2024072610152966300_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1523-1755.2003.00129.x","article-title":"Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease","volume":"64","author":"Sawaya","year":"2003","journal-title":"Kidney Int"},{"key":"2024072610152966300_bib33","first-page":"1642","article-title":"Racial differences in parathyroid hormone dynamics","volume":"79","author":"Fuleihan","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2024072610152966300_bib34","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.1997.12.6.958","article-title":"Resistance to bone resorbing effects of PTH in black women","volume":"12","author":"Cosman","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024072610152966300_bib35","first-page":"292","article-title":"The parathyroid gland in health and disease","volume":"125","author":"Ghandur-Mnaymneh","year":"1986","journal-title":"Am J Pathol"},{"key":"2024072610152966300_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00774-010-0186-z","article-title":"Comparisons of trabecular and cortical bone in late adolescent black and white females","volume":"29","author":"Pollock","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"2024072610152966300_bib37","doi-asserted-by":"crossref","first-page":"E149","DOI":"10.1210\/jc.2013-3148","article-title":"Serum sclerostin levels vary with season","volume":"99","author":"Dawson-Hughes","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024072610152966300_bib38","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1210\/jcem.87.5.8475","article-title":"Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women","volume":"87","author":"Rapuri","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2024072610152966300_bib39","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"Ryan","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024072610152966300_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5414\/CN111111","article-title":"FGF-23 and sclerostin in serum and bone of CKD patients","volume":"99","author":"Lima","year":"2023","journal-title":"Clin Nephrol"},{"key":"2024072610152966300_bib41","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"J Biol Chem"},{"key":"2024072610152966300_bib42","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024072610152966300_bib43","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2024072610152966300_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00467-011-2086-4","article-title":"Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23","volume":"27","author":"Narazaki","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"2024072610152966300_bib45","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1046\/j.1365-2133.2003.05273.x","article-title":"Phacomatosis pigmentokeratotica associated with hypophosphataemic vitamin D-resistant rickets: improvement in phosphate homeostasis after partial laser ablation","volume":"148","author":"Saraswat","year":"2003","journal-title":"Br J Dermatol"},{"key":"2024072610152966300_bib46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0887-8994(91)90030-O","article-title":"Giant nevocellular nevi with rickets and brainstem tumor","volume":"7","author":"Shieh","year":"1991","journal-title":"Pediatr Neurol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfae188\/58290996\/sfae188.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/7\/sfae188\/58656617\/sfae188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/7\/sfae188\/58656617\/sfae188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T10:16:24Z","timestamp":1721988984000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfae188\/7696747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfae188","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"type":"print","value":"2048-8505"},{"type":"electronic","value":"2048-8513"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,6,20]]},"article-number":"sfae188"}}